Optimisation of detecting chronic thromboembolic pulmonary hypertension in acute pulmonary embolism survivors: the InShape IV study.


Journal

The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460

Informations de publication

Date de publication:
27 Jun 2024
Historique:
received: 25 03 2024
accepted: 02 06 2024
medline: 28 6 2024
pubmed: 28 6 2024
entrez: 27 6 2024
Statut: aheadofprint

Résumé

Chronic thromboembolic pulmonary hypertension (CTEPH) is often diagnosed late in acute pulmonary embolism (PE) survivors: more efficient testing to expedite diagnosis may considerably improve patient outcomes. The InShape II algorithm safely rules out CTEPH (failure rate 0.29%) while requiring echocardiography in only 19% of patients but may be improved by adding detailed reading of the computed tomography pulmonary angiography (CTPA) diagnosing the index PE. Twelve new algorithms, incorporating the CTEPH prediction score, ECG reading, NT-proBNP levels and dedicated CTPA reading were evaluated in the international InShape II (n=341) and part of the German FOCUS cohort (n=171). Evaluation criteria included failure rate, defined as the incidence of confirmed CTEPH in PE patients in whom echocardiography was deemed unnecessary by the algorithm, and the overall net reclassification index (NRI) compared to the InShape II algorithm. The algorithm starting with CTPA reading of the index PE for 6 signs of CTEPH, followed by the ECG/NTproBNP assessment and echocardiography resulted in the most beneficial change compared to InShape II with a need for echocardiography in 20% (+5%), a failure rate of 0%, and an NRI of +3.5, reflecting improved performance over the InShape II algorithm. In the FOCUS cohort, this approach lowered echocardiography need to 24% (-6%) and missed no CTEPH cases, with an NRI of +6.0. Dedicated CTPA reading of the index PE improved the performance of the InShape II algorithm and may improve the selection of PE survivors who require echocardiography to rule out CTEPH.

Identifiants

pubmed: 38936968
pii: 13993003.00544-2024
doi: 10.1183/13993003.00544-2024
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright ©The authors 2024. For reproduction rights and permissions contact permissions@ersnet.org.

Auteurs

Dieuwke Luijten (D)

Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands d.luijten@lumc.nl.

Luca Valerio (L)

Department of Cardiology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
Center for Thrombosis and Hemostasis (CTH), University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.

Gudula J A M Boon (GJAM)

Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.

Stefano Barco (S)

Center for Thrombosis and Hemostasis (CTH), University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.
Clinic of Angiology, University Hospital Zurich, Zurich, Switzerland.

Harm Jan Bogaard (HJ)

Department of Pulmonary Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands.

Marion Delcroix (M)

Clinical Department of Respiratory Diseases, University Hospitals of Leuven and Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven - University of Leuven, Leuven, Belgium.

Yvonne Ende-Verhaar (Y)

Department of Internal Medicine, Haaglanden Medisch Centrum, the Hague, the Netherlands.

Menno V Huisman (MV)

Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.

Luis Jara-Palomares (L)

Respiratory Department, Virgen del Rocío Hospital and Instituto de Biomedicina, Sevilla, Spain.
CIBERES, Carlos III Health Institute, Madrid, Spain.

Karl-Friedrich Kreitner (KF)

Department of Radiology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.

Lucia J M Kroft (LJM)

Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.

Albert Ta Mairuhu (AT)

Department of Internal Medicine, Haga Teaching Hospital, The Hague, The Netherlands.

Anna C Mavromanoli (AC)

Center for Thrombosis and Hemostasis (CTH), University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.

Lilian J Meijboom (LJ)

Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands.

Thijs E van Mens (TE)

Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.

Maarten K Ninaber (MK)

Department of pulmonology, Leiden University Medical Center, Leiden, The Netherland.

Esther J Nossent (EJ)

Department of Pulmonary Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands.

Piotr Pruszczyk (P)

Department of Internal Medicine and Cardiology, Medical University of Warsaw, Warszawa, Poland.

Stephan Rosenkranz (S)

Department of Cardiology, Heart Center at the University Hospital Cologne, and Cologne Cardiovascular Research Center, Cologne, Germany.

Hubert Vliegen (H)

Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.

Anton Vonk Noordegraaf (A)

Department of Pulmonary Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands.

Stavros V Konstantinides (SV)

Center for Thrombosis and Hemostasis (CTH), University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.
Department of Cardiology, Democritus University of Thrace, Xanthi, Greece.

Frederikus A Klok (FA)

Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.
Center for Thrombosis and Hemostasis (CTH), University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.

Classifications MeSH